복분자 씨 기름을 함유하는 알레르기, 아토피 피부염 치료 및 개선용 조성물
    1.
    发明公开
    복분자 씨 기름을 함유하는 알레르기, 아토피 피부염 치료 및 개선용 조성물 无效
    包含RUBUS COREANUS MIQUEL SEED油的抗过敏组合物

    公开(公告)号:KR1020120086855A

    公开(公告)日:2012-08-06

    申请号:KR1020110008162

    申请日:2011-01-27

    Inventor: 황재관 최유리

    CPC classification number: A61K36/73 A61K8/922 Y10S514/857

    Abstract: PURPOSE: A composition containing Rubus coreanus Miquel seed oil is provided to suppress mast cell degranulation and cytokine production and to prevent and treat allergy and atopic dermatitis. CONSTITUTION: A composition for anti-allergy and anti-atopic dermatitis contains Rubus coreanus Miquel seed oil. The composition contains the oil as a main ingredient and suppresses mast cell degranulation. The composition is applied to foods, dietary supplements, cosmetic products, medicinal products, and feed.

    Abstract translation: 目的:提供含有Rubus coreanus Miquel种子油的组合物,以抑制肥大细胞脱粒和细胞因子的产生,并预防和治疗过敏和特应性皮炎。 构成:抗过敏和抗特应性皮炎的组合物含有Rubus coreanus Miquel种子油。 组合物含有油作为主要成分并抑制肥大细胞脱粒。 该组合物适用于食品,膳食补充剂,化妆品,药​​用产品和饲料。

    노르디히드로구아야레트산을 포함하는 지방간 개선용 조성물
    2.
    发明公开
    노르디히드로구아야레트산을 포함하는 지방간 개선용 조성물 无效
    含有非糖尿病酸的抗脂肪肝组合物

    公开(公告)号:KR1020120078834A

    公开(公告)日:2012-07-11

    申请号:KR1020110000106

    申请日:2011-01-03

    Abstract: PURPOSE: A composition containing nordihydroguaiaretic acid is provided to suppress FAS, ACC, and SREBP-1c expression and to prevent fat accumulation in the liver. CONSTITUTION: A composition for treating fatty liver contains nordihydroguaiaretic acids of chemical formula 1 as an active ingredient. The composition activates AMPK and suppresses lipid synthesis in the liver using nordihydroguaiaretic acids as a main component. A composition for treating and preventing fatty liver disorders contains nordihydroguaiaretic acids as an active ingredient. A health functional food composition for treating fatty liver disorder contains nordihydroguaiaretic acids as an active ingredient.

    Abstract translation: 目的:提供含有去甲二氢愈创木酸的组合物,以抑制FAS,ACC和SREBP-1c的表达,并防止肝脏脂肪堆积。 构成:用于治疗脂肪肝的组合物含有化学式1的去甲二氢愈创木酸作为活性成分。 该组合物使用去甲二氢愈创木酸作为主要成分激活AMPK并抑制肝脏中的脂质合成。 用于治疗和预防脂肪肝疾病的组合物含有去甲二氢愈创木酸作为活性成分。 用于治疗脂肪肝疾病的健康功能食品组合物含有去甲二氢愈创木酸作为活性成分。

    산화물 박막용 조성물, 산화물 박막용 조성물 제조 방법, 산화물 박막용 조성물을 이용한 산화물 박막 및 전자소자
    3.
    发明公开
    산화물 박막용 조성물, 산화물 박막용 조성물 제조 방법, 산화물 박막용 조성물을 이용한 산화물 박막 및 전자소자 无效
    氧化物薄膜的组合物,组合物的制备方法,使用该组合物形成氧化物薄膜的方法和使用组合物的电子装置

    公开(公告)号:KR1020120077787A

    公开(公告)日:2012-07-10

    申请号:KR1020100139869

    申请日:2010-12-31

    Abstract: PURPOSE: A composition for oxide film, a manufacturing method thereof, oxide thin film and electric component using the composition for oxide thin films are provided to improve electrical properties of the electric components by including indium, zinc and scandium which has low electronegativity. CONSTITUTION: A composition for oxide film comprises a first compound, a second compound and a third compound. The first compound comprises tin or indium. The second compound comprises zinc. The third compound includes scandium. 1-99 atomic% of scandium is included based on total atom number of zinc and indium or zinc and tin. The atomic ratio of zinc to indium or zinc to tin is 1:5-5:1. The third compound comprises scandium acetate hydrate, scandium acetylacetonate hydrate, scandium chloride, scandium chloride hexahydrate, scandium chloride hydrate, scandium fluoride, scandium nitrate hydrate or a combination thereof. The electric component comprises the oxide semiconductor thin film. The oxide semiconductor thin film comprises indium or tin, zinc, and scandium.

    Abstract translation: 目的:提供一种氧化膜用组合物,其制造方法,氧化物薄膜和使用该氧化物薄膜用组合物的电气成分,以通过包含具有低电负性的铟,锌和钪来改善电气部件的电特性。 构成:用于氧化膜的组合物包含第一化合物,第二化合物和第三化合物。 第一种化合物包括锡或铟。 第二种化合物包括锌。 第三种化合物包括钪。 基于锌和铟或锌和锡的总原子数,包括1-99原子%的钪。 锌与铟或锡的原子比为1:5-5:1。 第三种化合物包括乙酸钪水合物,乙酰丙酮onate水合物,氯化钪,氯化钪六水合物,氯化钪水合物,氟化钪,硝酸钪水合物或其组合。 电气部件包括氧化物半导体薄膜。 氧化物半导体薄膜包括铟或锡,锌和钪。

    판두라틴 에이 또는 보에센베르기아 판두라타 추출물을 함유하는 아토피성 피부질환의 예방 및 치료용 조성물
    4.
    发明公开
    판두라틴 에이 또는 보에센베르기아 판두라타 추출물을 함유하는 아토피성 피부질환의 예방 및 치료용 조성물 无效
    包含PANDURATIN A或BOESENBERGIA PANDURATA提取物的抗真菌剂组合物

    公开(公告)号:KR1020120113201A

    公开(公告)日:2012-10-12

    申请号:KR1020120035150

    申请日:2012-04-04

    Abstract: PURPOSE: A composition containing panduratin A or Boesenbergia pandurata extract is provided to suppress pruritus and to prevent and treat atopic dermatitis. CONSTITUTION: A composition for preventing and treating atopic dermatitis contains panduratin A of chemical formula 1 or Boesenbergia pandurata extract. Panduratin A is isolated from Boesenbergia pandurata. The atopic dermatitis includes xeroderma, erythema, kiratinization, and pruritus. Pruritus causes mast cell degranulation.

    Abstract translation: 目的:提供含有潘多汀A或勃林氏菌提取物的组合物以抑制瘙痒并预防和治疗特应性皮炎。 构成:用于预防和治疗特应性皮炎的组合物含有化学式1或泛黄柏提取物的潘多汀A。 Panduratin A从Boesenbergia pandurata中分离出来。 特应性皮炎包括皮肤病,红斑,kiratinization和瘙痒。 瘙痒引起肥大细胞脱颗粒。

Patent Agency Ranking